Livforsakringsbolaget Skandia, Omsesidigt Lannett CO Inc Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 07, 2021	SELL	$5.28 - $9.64 $238,128 - $434,764	-45,100 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$19.9 - $29.25 $897,489 - $1.32 Million	45,100	45,100 $1.05 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.